跳至主要内容
临床试验/NCT03906617
NCT03906617招募中4 期

Title of Project: Liposomal Bupivacaine (Exparel) Versus Bupivacaine And Dexamethasone Intercostal Nerve Blocks For Robotic Thoracic Surgery: A Prospective Randomized Single-Blinded Clinical Trial

The Cooper Health System1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2019年4月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
34
试验地点
1
主要终点
Visual Analogue Scale pain scores

研究概览

简要总结

This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing robotic wedge resection or lobectomy for lung mass(es)

排除标准

  • emergency case
  • history of opiate abuse
  • chronic pain syndrome
  • intravenous drug use
  • chronic use of oral steroids
  • pregnancy
  • imprisonment
  • body weight lower than 70 kg
  • liver failure
  • uninsured patients
  • non-verbal patients or patients who are unable to rate their pain on a visual analogue pain scale
  • history of allergic reaction to any of the drugs used in the study: bupivacaine, liposomal bupivacaine, dexamethasone

研究组 & 干预措施

Bupivacaine/epinephrine + dexamethasone

Experimental

干预措施: Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone (Drug)

Liposomal bupivacaine

Active Comparator

干预措施: Intercostal nerve block and wound infiltration with liposomal bupivacaine (Drug)

结局指标

主要结局

Visual Analogue Scale pain scores

时间窗: 24 hours post-surgery

Visual Analogue Scale (VAS) pain score will be assessed for non-inferiority of bupivacaine/epinephrine +dexamethasone vs. liposomal bupivacaine. A non-inferiority margin of 2 points on the VAS scale will be considered non-inferior.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kingsuk Ganguly, M.D.

Assistant Professor of Anesthesiology

The Cooper Health System

研究点 (1)

Loading locations...

相似试验